4.7 Letter

Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation

Journal

CLINICAL MICROBIOLOGY AND INFECTION
Volume 28, Issue 12, Pages 1657-1658

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2022.06.029

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available